Mesoblast could need another COVID trial says CEO
MELBOURNE: Losses at stem cell treatments producer Mesoblast have hit $US98.8 million ($135 million) for… read more
Healius eyes M&A after sales surge says CEO
MELBOURNE: Healius boss Malcolm Parmenter says the healthcare giant is seeking to make bolt-on purchases… read more
16 new senior healthcare executives sought for key roles
MELBOURNE: Sixteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
Regis Healthcare set to reinstate final dividend
MELBOURNE: Regis Healthcare has reinstated its final dividend despite a host of issues last financial… read more
